Table 5 Multivariable logistic regression analysis for predictive factors of response to chemotherapy plus nivolumab treatment.

From: Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study

Factors

Wald X2

p value

OR

95% CI

NLR

0.007

0.935

1.036

0.439–2.445

PLR

0.690

0.406

0.652

0.237–1.789

SII

6.803

0.009

3.931

1.405–10.997

ECOG PS

0.924

0.336

1.324

0.747–2.349

PD-L1 CPS

4.933

0.026

0.641

0.433–0.949

  1. OR: Odds ratio, CI: Confidence interval; NLR: neutrophil-lymphocyte ratio; PLR: platelet-lymphocyte ratio. SII, Systemic Immune-Inflammation Index; ECOG, Eastern Cooperative Oncology Group; PD-L1: programmed death-ligand 1; CPS, combined positive score.
Back to article page